Tag: post-marketing pharmacovigilance and medical information market drivers

  • Global Post-Marketing Pharmacovigilance And Medical Information Market 2025–2029: Competitive Insights and Opportunities

    Global Post-Marketing Pharmacovigilance And Medical Information Market 2025–2029: Competitive Insights and Opportunities

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Expected Total Market Size Of The Post-Marketing Pharmacovigilance And Medical Information Industry By The Forecast Year 2029?

    The post-marketing pharmacovigilance and medical information market has experienced significant expansion recently. It is forecast to grow from $6.16 billion in 2024 to $6.90 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.9%. This historical growth can be linked to factors such as the increasing integration of AI in pharmacovigilance processes, a heightened demand for outsourced drug safety services, the rising complexity of biopharmaceutical products, an increasing focus on patient-reported outcomes, and greater collaboration between regulatory agencies and the industry.

    The post-marketing pharmacovigilance and medical information market size is projected for substantial expansion in the coming years. This market is anticipated to reach $10.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This projected growth is driven by several factors, including enhanced drug safety analytics tools, a greater uptake of cloud-based pharmacovigilance solutions, an increase in the introduction of new therapeutic products, a heightened focus on proactive risk management approaches, and expanding pharmacovigilance demands in developing regions. Key trends anticipated during this period encompass progress in automated adverse event detection, the creation of integrated pharmacovigilance platforms, breakthroughs in real-time safety data surveillance, improvements in patient engagement instruments for reporting safety information, and the evolution of predictive analytics for evaluating drug risks.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

    What Are The Main Drivers Boosting The Post-Marketing Pharmacovigilance And Medical Information Industry’s Expansion?

    The expanding occurrence of adverse drug reactions is projected to fuel the growth of the post-marketing pharmacovigilance and medical information market moving forward. These reactions refer to harmful or unintended effects experienced when a medication is taken at its recommended dosage for prevention, diagnosis, or treatment. The prevalence of adverse drug reactions is increasing due to the aging population’s growing need for treatment of multiple chronic conditions. This often results in the concurrent use of several medications, heightening the probability of adverse drug interactions and unexpected side effects. Post-marketing pharmacovigilance and medical information are essential in managing adverse drug reactions by detecting, tracking, and sharing details about potential side effects after a drug is launched, thereby helping to maintain its safety and effectiveness. A notable example is from January 2023, when Navikenz, a US-based artificial intelligence-focused IT services company, reported that in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, a figure exceeding the combined fatalities from stroke and diabetes. Furthermore, roughly 2.7 million cases each year result in over 100,000 hospitalizations and more than 15,000 deaths. This rising incidence of adverse drug reactions is thus driving the growth of the post-marketing pharmacovigilance and medical information market.

    How Is The Post-Marketing Pharmacovigilance And Medical Information Market Segmented?

    The post-marketing pharmacovigilance and medical information market covered in this report is segmented

    1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

    2) By Product: Books, Online Media, Journals

    3) By End User: Hospitals, Research Organizations, Other End-Users

    Subsegments:

    1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

    2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

    3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

    4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

    5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

    Which Key Trends Are Expected To Influence The Post-Marketing Pharmacovigilance And Medical Information Market In The Coming Years?

    Key players within the post-marketing pharmacovigilance and medical information market are primarily focused on developing advanced solutions, such as AI-powered pharmacovigilance workflows, to improve the accuracy of adverse event detection and enable continuous safety monitoring for enhanced patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, thereby accelerating the identification of adverse events and boosting regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, launched a centralized Summary of Product Characteristics (SmPC) management system tailored for life science companies and research organizations. This innovative platform unifies essential drug safety information into one easily accessible location, automates the surveillance of literature and regulatory submissions, strengthens team collaboration, and streamlines compliance processes through its sophisticated AI functionalities. As a result, pharmacovigilance teams can operate more effectively and preemptively, ensuring both patient safety and adherence to regulatory mandates.

    Which Global Market Leaders Are Shaping The Future Of The Post-Marketing Pharmacovigilance And Medical Information Sector?

    Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

    Which Region Is Expected To Witness The Fastest Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

    North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Post-Marketing Pharmacovigilance And Medical Information Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

    Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2025, By The Business Research Company

    Drain Cleaning Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

    Urinary Drainage Bags Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

    Prefabricated Buildings Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Competitive and Market Trend Analysis of Post-Marketing Pharmacovigilance And Medical Information Industry Through 2029

    Competitive and Market Trend Analysis of Post-Marketing Pharmacovigilance And Medical Information Industry Through 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Will the Post-Marketing Pharmacovigilance And Medical Information Market Evolve in Terms of Growth and Size by 2029?

    The market size for post-marketing pharmacovigilance and medical information has seen significant growth in the past few years and is expected to increase from $6.16 billion in 2024 to $6.90 billion in 2025. This represents a compound annual growth rate (CAGR) of 11.9%. The historic growth of this sector is a result of the rising implementation of Artificial Intelligence in pharmacovigilance procedures, growing demand for contracted drug safety services, increased complexity in biopharmaceutical products, a heightened emphasis on patient-reported outcomes, and more collaborations between regulatory authorities and the industry.

    The market size for post-marketing pharmacovigilance and medical information is projected to experience accelerated growth in the coming years, swelling to $10.68 billion by 2029 at a compound annual growth rate of 11.6%. The growth foreseen in this period can be attributed to factors such as progress in drug safety analytics tools, increased usage of cloud-based pharmacovigilance solutions, frequent introductions of novel therapeutics, heightened focus on proactive risk management strategies, and an expansion in pharmacovigilance obligations in emerging markets. Key trends in the forecast period include the evolution in automated adverse event detection, the emergence of integrated pharmacovigilance platforms, breakthroughs in real-time safety data monitoring, advancements in patient engagement tools for safety reporting, and the development of predictive analytics for assessing drug risk.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

    What factors are expected to fuel Post-Marketing Pharmacovigilance And Medical Information market growth in the coming years?

    The escalating occurrence of negative effects from medications is anticipated to drive the expansion of the post-marketing pharmacovigilance and medical information market. When a drug is used at its prescribed level for prevention, diagnosis, or treatment, adverse drug reactions, essentially harmful or unintended effects, can occur. As the elderly population requiring treatment for multiple chronic conditions increases, so does the likelihood of adverse drug reactions due to the concurrent usage of various medications. This raises the probability of unexpected side effects and detrimental drug interactions. Through detection, tracking, and information sharing about possible side effects post-medication launch, post-marketing pharmacovigilance and medical information promote the management of these adverse effects, thereby ensuring the safety and efficacy of the medication. To illustrate, Navikenz, a US AI-focused IT services company, reported in January 2023 that the US sees an estimated 200,000 to 400,000 deaths annually due to adverse drug reactions, a toll higher than that of stroke and diabetes combined. Approximately 2.7 million cases each year result in over 100,000 hospitalizations and progress to more than 15,000 deaths. Hence, the escalating occurrence of adverse drug reactions is bolstering the expansion of the post-marketing pharmacovigilance and medical information market.

    What Are The Key Findings From The Segmentation Analysis Of The Post-Marketing Pharmacovigilance And Medical Information Market?

    The post-marketing pharmacovigilance and medical information market covered in this report is segmented

    1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

    2) By Product: Books, Online Media, Journals

    3) By End User: Hospitals, Research Organizations, Other End-Users

    Subsegments:

    1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

    2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

    3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

    4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

    5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

    Which Trends Are Expected To Shape The Future Of The Post-Marketing Pharmacovigilance And Medical Information Market?

    Leading corporations in the post-marketing pharmacovigilance and medical information industry are concentrating on creating state-of-the-art solutions such as AI-powered pharmacovigilance workflows. These workflows are designed to increase the effectiveness of adverse event identification and provide real-time safety monitoring for improved patient results. They leverage artificial intelligence to mechanize drug safety monitoring, resulting in expedited event detection and better adherence to regulatory norms. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based Software-as-a-service (SaaS) firm, rolled out a centralized Summary of Product Characteristics (SmPC) management intended for life science firms and research organizations. The platform amalgamates key drug safety data into a singular, accessible repository and mechanizes literature surveillance and regulatory reporting. It also encourages team synergy and seamless compliance through the application of advanced AI. This allows pharmacovigilance squads to run more productively and proactively, thereby guaranteeing patient safety and observance of regulatory requirements.

    What Are The Most Active Companies In The Post-Marketing Pharmacovigilance And Medical Information Market Today?

    Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

    Which Regional Markets Are Attracting The Most Investment In Post-Marketing Pharmacovigilance And Medical Information?

    North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model